
Misook Yu
Supervisory Patent Examiner (ID: 2708, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 864 |
| Issued Applications | 263 |
| Pending Applications | 201 |
| Abandoned Applications | 403 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5410049
[patent_doc_number] => 20090123948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Autoantibody detection for cancer diagnostics'
[patent_app_type] => utility
[patent_app_number] => 10/592040
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7779
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592040 | Autoantibody detection for cancer diagnostics | Mar 6, 2005 | Issued |
Array
(
[id] => 7246982
[patent_doc_number] => 20050272063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Method for treating synovial sarcoma'
[patent_app_type] => utility
[patent_app_number] => 11/067231
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29206
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11067231
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/067231 | Method for treating synovial sarcoma | Feb 27, 2005 | Issued |
Array
(
[id] => 7004618
[patent_doc_number] => 20050169931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'EphA2 as a therapeutic target for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/063101
[patent_app_country] => US
[patent_app_date] => 2005-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5898
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169931.pdf
[firstpage_image] =>[orig_patent_app_number] => 11063101
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/063101 | EphA2 as a therapeutic target for cancer | Feb 21, 2005 | Abandoned |
Array
(
[id] => 6911876
[patent_doc_number] => 20050175634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction'
[patent_app_type] => utility
[patent_app_number] => 11/061996
[patent_app_country] => US
[patent_app_date] => 2005-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12416
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175634.pdf
[firstpage_image] =>[orig_patent_app_number] => 11061996
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/061996 | Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction | Feb 20, 2005 | Abandoned |
Array
(
[id] => 359543
[patent_doc_number] => 07485422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-03
[patent_title] => 'Detection of CDX2 expression'
[patent_app_type] => utility
[patent_app_number] => 11/058778
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14340
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/485/07485422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11058778
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/058778 | Detection of CDX2 expression | Feb 15, 2005 | Issued |
Array
(
[id] => 4651029
[patent_doc_number] => 20080038285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Method for Identifying and Quantifying of Tumour-Associated'
[patent_app_type] => utility
[patent_app_number] => 10/587876
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7692
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587876 | Method for identifying and quantifying of tumuor-associated | Jan 27, 2005 | Issued |
Array
(
[id] => 4663126
[patent_doc_number] => 20080254033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases'
[patent_app_type] => utility
[patent_app_number] => 10/586669
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20161
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586669 | Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases | Jan 20, 2005 | Abandoned |
Array
(
[id] => 4663126
[patent_doc_number] => 20080254033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases'
[patent_app_type] => utility
[patent_app_number] => 10/586669
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20161
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586669 | Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7110563
[patent_doc_number] => 20050208018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth'
[patent_app_type] => utility
[patent_app_number] => 11/040162
[patent_app_country] => US
[patent_app_date] => 2005-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 19873
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040162
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040162 | Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth | Jan 19, 2005 | Issued |
Array
(
[id] => 5296025
[patent_doc_number] => 20090010951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same'
[patent_app_type] => utility
[patent_app_number] => 10/586852
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13837
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586852 | Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same | Jan 18, 2005 | Issued |
Array
(
[id] => 7196119
[patent_doc_number] => 20050164267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'
[patent_app_type] => utility
[patent_app_number] => 11/036875
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14322
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164267.pdf
[firstpage_image] =>[orig_patent_app_number] => 11036875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/036875 | Compositions and methods for identifying and targeting cancer cells of alimentary canal origin | Jan 13, 2005 | Issued |
Array
(
[id] => 4473982
[patent_doc_number] => 07867705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-11
[patent_title] => 'Frizzled proteins and detection and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/575627
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 48
[patent_no_of_words] => 36181
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/867/07867705.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575627
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575627 | Frizzled proteins and detection and treatment of cancer | Jan 4, 2005 | Issued |
Array
(
[id] => 7103894
[patent_doc_number] => 20050106620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Novel method of diagnosing, monitoring, staging, imaging and treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/022712
[patent_app_country] => US
[patent_app_date] => 2004-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6832
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022712
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022712 | Novel method of diagnosing, monitoring, staging, imaging and treating cancer | Dec 26, 2004 | Abandoned |
Array
(
[id] => 7045532
[patent_doc_number] => 20050250127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Methods for identifying modulators of MDA-7 mediated apoptosis'
[patent_app_type] => utility
[patent_app_number] => 11/019897
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14987
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250127.pdf
[firstpage_image] =>[orig_patent_app_number] => 11019897
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/019897 | Methods for identifying modulators of MDA-7 mediated apoptosis | Dec 21, 2004 | Abandoned |
Array
(
[id] => 7219161
[patent_doc_number] => 20050260555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Chemosensitivity measurement using caspase activity'
[patent_app_type] => utility
[patent_app_number] => 10/999158
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4446
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260555.pdf
[firstpage_image] =>[orig_patent_app_number] => 10999158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999158 | Chemosensitivity measurement using caspase activity | Nov 29, 2004 | Abandoned |
Array
(
[id] => 6983262
[patent_doc_number] => 20050153332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Method of diagnosing, monitoring, staging, imaging and treating colon cancer'
[patent_app_type] => utility
[patent_app_number] => 11/000263
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25978
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153332.pdf
[firstpage_image] =>[orig_patent_app_number] => 11000263
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/000263 | Method of diagnosing, monitoring, staging, imaging and treating colon cancer | Nov 29, 2004 | Abandoned |
Array
(
[id] => 7005703
[patent_doc_number] => 20050171016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Thrombospondin-2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/997699
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25903
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997699 | Thrombospondin-2 and uses thereof | Nov 23, 2004 | Abandoned |
Array
(
[id] => 7074768
[patent_doc_number] => 20050148036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Method for detecting a mononuclear cell phenotype related to a pro-tumor immune response'
[patent_app_type] => utility
[patent_app_number] => 10/997648
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19246
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997648 | Method for detecting a mononuclear cell phenotype related to a pro-tumor immune response | Nov 23, 2004 | Abandoned |
Array
(
[id] => 142063
[patent_doc_number] => 07691817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'System and method for inhibiting cellular proliferation with tachykinins'
[patent_app_type] => utility
[patent_app_number] => 10/994170
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 17834
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994170 | System and method for inhibiting cellular proliferation with tachykinins | Nov 18, 2004 | Issued |
Array
(
[id] => 4733417
[patent_doc_number] => 20080050396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients'
[patent_app_type] => utility
[patent_app_number] => 10/580016
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20809
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580016
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580016 | Proteins belonging to the Bcl-2 family and fragments thereof, and their use in cancer patients | Nov 17, 2004 | Issued |